← Eichor
Study identifier: NCT07241949 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

External Oblique Intercostal Block (EOICB) for Laparoscopic Cholecystectomy

Condition: Postoperative Pain · Laparoscopic Cholecystectomy · Paravertebral Block  ·  Sponsor: Cukurova University

PhaseNA
Planned participants147
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This single-center, prospective, randomized controlled trial aims to compare the effects of paravertebral block (PVB), external oblique intercostal (EOI) block, and intravenous patient-controlled analgesia (PCA) with tramadol on postoperative pain and opioid consumption in patients undergoing elective laparoscopic cholecystectomy. The primary endpoint is total tramadol consumption within 24 hours postoperatively. Secondary outcomes include pain scores, additional analgesic use, incidence of nausea/vomiting, mobilization time, and length of hospital stay.

This description comes directly from the study's public registry record.

Talk to the study team

Nurefsan Sadikoglu, MD  ·  +(90) 538 926 2414  ·  nurefsansadikoglu@gmail.com

Zehra Hatipoglu, MD  ·  +(90) 532 447 1670  ·  hatipogluzehra@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Cukurova University Faculty of MedicineAdana, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07241949